BD Statement on FDA Circulatory System Devices Panel Regarding Paclitaxel-Coated Devices - Vascular Disease Management
BD Statement on FDA Circulatory System Devices Panel Regarding Paclitaxel-Coated Devices Vascular Disease Management
FRANKLIN LAKES, N.J. , June 20, 2019 — BD ( Becton, Dickinson and Company ) issued the following statement following the U.S. Food and Drug ...
Comments
Post a Comment